Improving the efficacy and effectiveness of evidence-based psychosocial interventions for attention-deficit/hyperactivity disorder (ADHD) in children and adolescents
- PMID: 38851829
- PMCID: PMC11162428
- DOI: 10.1038/s41398-024-02890-3
Improving the efficacy and effectiveness of evidence-based psychosocial interventions for attention-deficit/hyperactivity disorder (ADHD) in children and adolescents
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is a prevalent, chronic, and impairing mental health disorder of childhood. Decades of empirical research has established a strong evidence-based intervention armamentarium for ADHD; however, limitations exist in regards to efficacy and effectiveness of these interventions. We provide an overview of select evidence-based interventions for children and adolescents, highlighting potential approaches to further improving the efficacy and effectiveness of these interventions. We conclude with broader recommendations for interventions, including considerations to moderators and under-explored intervention target areas as well as avenues to improve access and availability of evidence-based interventions through leveraging underutilized workforces and leveraging technology.
© 2024. The Author(s).
Conflict of interest statement
MJK holds a patent for neurocognitive interventions that target central executive working memory and inhibitory control and that were recently licensed to Sky Therapeutics, a company for which MJK provides consulting and holds equity.
References
-
- Barbaresi WJ, Campbell L, Diekroger EA, Froehlich TE, Liu YH, O’Malley, et al. Society for Developmental and Behavioral Pediatrics clinical practice guideline for the assessment and treatment of children and adolescents with complex attention-deficit/hyperactivity disorder. J Dev Behav Pediatr. 2020;41:S35–S57. doi: 10.1097/DBP.0000000000000770. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
